Health Trials

Cardiac RadiothErapy for VEntricular Tachycardia II

ConditionVentricular Tachycardia (VT)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven

About this trial

Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.

Eligibility criteria

Qualifiers

Eligible for STAR for therapy-refractory VT based on a multidisciplinary discussion

Ability to give a written informed consent and willingness to return for follow-up

Disqualifiers

Contra-indications for STAR, including pregnancy or breastfeeding, previous radiotherapy with cardiac involvement, life-expectancy < 6 months in the absence of VT

Any condition that is deemed a contraindication in the judgment of the investigators

Trial design

Treatments tested in this trial

  • stereotactic radiotherapy ablation

Treatment groups

No treatment groups listed

Locations

1
UZ Leuven3000, Leuven Belgium

Sponsors and collaborators

Universitaire Ziekenhuizen KU Leuven

Lead sponsor

Source ClinicalTrials.gov